Implementation of a patient selection protocol for intra-arterial therapy increases treatment rates in patients with acute ischemic stroke

Background Strategies for patient selection for intra-arterial therapy (IAT) in acute ischemic stroke (AIS) are highly variable. The degree of protocol adoption and treatment rates associated with implementation of a service-wide patient selection IAT protocol were assessed. Methods All patients with AIS prospectively recorded in our stroke database from January 2007 to June 2009 were reviewed. The IAT patient selection protocol was implemented in March 2008. Patients were defined as likely to benefit (LTB) from IAT if they had brain imaging completed within 6 h from last known well time, NIH Stroke Scale score ≥8, infarct volume ≤100 ml and evidence of proximal artery occlusion. Results Of 1348 subjects identified, 118 (8.7%) met the criteria for LTB and 62 (52%) underwent IAT. There was a significant increase in rates of IAT among LTB patients after protocol implementation (61% vs 40%, p<0.02). In LTB patients, factors associated with IAT were stroke duration (OR 0.78, 95% CI 0.6 to 0.9 per hour), arrival within later calendar months during study period (OR 1.1, 95% CI 1.02 to 1.2 per month), intravenous tissue plasminogen activator (OR 0.6, 95% CI 0.4 to 0.9) and age (OR 0.98, 95% CI 0.95 to 1.02 per year). After multivariable adjustment, only stroke duration (OR 0.65, 95% CI 0.5 to 0.8 per hour) remained an independent predictor of IAT. Conclusions Most patients with AIS did not meet our criteria for LTB and only 52% of those defined as LTB received IAT. Protocol adoption increased the use of IAT over time; however, further exploration of factors associated with the reasons for non-treatment and the impact of IAT on outcomes is necessary.

[1]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[2]  M. Fisher,et al.  Current Practice Versus Willingness to Enroll in Clinical Trials: Paradox Among Vascular Neurologists About Treatment for Acute Ischemic Stroke , 2010, Stroke.

[3]  A. Abou-Chebl,et al.  Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients , 2010, Stroke.

[4]  Pamela W Schaefer,et al.  Combining Acute Diffusion-Weighted Imaging and Mean Transmit Time Lesion Volumes With National Institutes of Health Stroke Scale Score Improves the Prediction of Acute Stroke Outcome , 2010, Stroke.

[5]  J. Saver,et al.  Efficacy of Intra-Arterial Fibrinolysis for Acute Ischemic Stroke: Meta-Analysis of Randomized Controlled Trials , 2010, Stroke.

[6]  L. Schwamm,et al.  Case volumes of intra-arterial and intravenous treatment of ischemic stroke in the USA , 2009, Journal of NeuroInterventional Surgery.

[7]  B. Dunn,et al.  Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. , 2009, Stroke.

[8]  R. Gonzalez,et al.  MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization , 2009, Stroke.

[9]  A. Padovani,et al.  Perfusion CT in Patients with Acute Ischemic Stroke Treated with Intra-Arterial Thrombolysis: Predictive Value of Infarct Core Size on Clinical Outcome , 2009, American Journal of Neuroradiology.

[10]  T. Mayer,et al.  The Penumbra System: A Mechanical Device for the Treatment of Acute Stroke due to Thromboembolism , 2008, American Journal of Neuroradiology.

[11]  H. Lutsep,et al.  Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial , 2008, Stroke.

[12]  G. Schroth,et al.  Comparison of Intraarterial and Intravenous Thrombolysis for Ischemic Stroke With Hyperdense Middle Cerebral Artery Sign , 2008, Stroke.

[13]  T. Neumann-Haefelin,et al.  MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients , 2007, Stroke.

[14]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[15]  G. Schroth,et al.  Reasons to withhold intra-arterial thrombolysis in clinical practice , 2006, Journal of Neurology.

[16]  H. Lutsep,et al.  Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial , 2005, Stroke.

[17]  R. Higashida,et al.  Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke , 2003, Stroke.

[18]  김용권,et al.  뇌졸중 환자의 임상적 검사NIHSS(National Institutes of Health Stroke Scale)와 기능적 예후와의 상관관계 , 2002 .

[19]  Christopher Putman,et al.  Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:: Prediction of Final Infarct Volume and Clinical Outcome , 2001, Stroke.

[20]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[21]  N. Petitti The hyperdense middle cerebral artery sign. , 1998, Radiology.